{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:07:26Z","timestamp":1785769646366,"version":"3.56.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.xcrm.2025.101981","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T16:07:16Z","timestamp":1740413236000},"page":"101981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["An epitope-directed mRNA vaccine inhibits tumor metastasis through the blockade of MICA\/B \u03b11\/2 shedding"],"prefix":"10.1016","volume":"6","author":[{"given":"Rui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingni","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7450-885X","authenticated-orcid":false,"given":"Yongliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.101981_bib1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm1469","article-title":"Tumor metastasis: mechanistic insights and clinical challenges","volume":"12","author":"Steeg","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.101981_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.101981_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.medj.2023.04.004","article-title":"A chimeric antigen receptor uniquely recognizing MICA\/B stress proteins provides an effective approach to target solid tumors","volume":"4","author":"Goulding","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.xcrm.2025.101981_bib4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.52586\/4986","article-title":"Expression of MHC class I polypeptide-related sequence A (MICA) in colorectal cancer","volume":"26","author":"Espinoza","year":"2021","journal-title":"Front. Biosci."},{"key":"10.1016\/j.xcrm.2025.101981_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13046-014-0076-7","article-title":"MICA\/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma","volume":"33","author":"Fang","year":"2014","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101981_bib6","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.4049\/jimmunol.169.10.5377","article-title":"Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin","volume":"169","author":"Hayakawa","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2025.101981_bib7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature05768","article-title":"Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands","volume":"447","author":"Kaiser","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.101981_bib8","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1182\/blood-2009-04-217430","article-title":"MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease","volume":"114","author":"Boukouaci","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101981_bib9","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1158\/0008-5472.CAN-09-0789","article-title":"Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma","volume":"69","author":"Kohga","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101981_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1158\/0008-5472.CAN-09-1688","article-title":"Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA\u2217008 that is shed by tumor cells in exosomes","volume":"70","author":"Ashiru","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101981_bib11","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.aao0505","article-title":"Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity","volume":"359","author":"Ferrari de Andrade","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.101981_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s40425-019-0687-9","article-title":"MICA immune complex formed with alpha 3 domain-specific antibody activates human NK cells in a Fc-dependent manner","volume":"7","author":"Du","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2025.101981_bib13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1158\/2326-6066.CIR-19-0483","article-title":"Inhibition of MICA and MICB shedding elicits NK-cell-mediated immunity against tumors resistant to cytotoxic T\u00a0cells","volume":"8","author":"Ferrari de Andrade","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2025.101981_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood.2021011619","article-title":"MICA\/B antibody induces macrophage-mediated immunity against acute myeloid leukemia","volume":"139","author":"Alves da Silva","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101981_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40425-019-0553-9","article-title":"Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA\/B and NKG2A targeting for cancer treatment","volume":"7","author":"Courau","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2025.101981_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3322\/caac.21596","article-title":"A review of cancer immunotherapy toxicity","volume":"70","author":"Kennedy","year":"2020","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2025.101981_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.xcrm.2025.101981_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12943-019-1055-6","article-title":"Neoantigen vaccine: an emerging tumor immunotherapy","volume":"18","author":"Peng","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2025.101981_bib19","article-title":"Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein","volume":"8","author":"Torres","year":"2020","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2025.101981_bib20","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41586-022-04772-4","article-title":"A vaccine targeting resistant tumours by dual T\u00a0cell plus NK cell attack","volume":"606","author":"Badrinath","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.101981_bib21","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1158\/0008-5472.CAN-13-3286","article-title":"Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity","volume":"74","author":"Cecil","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101981_bib22","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1002\/jmv.27926","article-title":"Longitudinal mapping of hepatitis B vaccine-induced B-cell linear epitopes in healthy individuals","volume":"94","author":"Zhong","year":"2022","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.xcrm.2025.101981_bib23","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.immuni.2021.10.017","article-title":"Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies","volume":"54","author":"Kratochvil","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.101981_bib24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/acsabm.1c01238","article-title":"Peptides for vaccine development","volume":"5","author":"Hamley","year":"2022","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.xcrm.2025.101981_bib25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.101981_bib26","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2021.02.030","article-title":"Novel approaches for vaccine development","volume":"184","author":"Gebre","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.101981_bib27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2014developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.101981_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303261","article-title":"Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy","volume":"35","author":"Zong","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2025.101981_bib29","doi-asserted-by":"crossref","first-page":"14748","DOI":"10.1021\/jacs.1c06600","article-title":"Trivalent subunit vaccine candidates for COVID-19 and their delivery devices","volume":"143","author":"Ortega-Rivera","year":"2021","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.xcrm.2025.101981_bib30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.122.061516","article-title":"Peptide vaccine against ADAMTS-7 ameliorates atherosclerosis and postinjury neointima hyperplasia","volume":"147","author":"Ma","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2025.101981_bib31","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1158\/1078-0432.CCR-22-3168","article-title":"Randomized, double-blind, placebo-controlled trial of MUC1 peptide vaccine for prevention of recurrent colorectal adenoma","volume":"29","author":"Schoen","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101981_bib32","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1158\/1078-0432.CCR-20-3742","article-title":"Clinical and immunologic responses to a B-cell epitope vaccine in patients with HER2\/neu-overexpressing advanced gastric cancer-results from Phase Ib Trial IMU.ACS.001","volume":"27","author":"Wiedermann","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101981_bib33","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1158\/0008-5472.CAN-11-2104","article-title":"Hypoxia induces escape from innate immunity in cancer cells via increased expression of ADAM10: role of nitric oxide","volume":"71","author":"Barsoum","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101981_bib34","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1158\/0008-5472.CAN-13-2563","article-title":"Metastatic consequences of immune\u00a0escape from NK cell cytotoxicity by human breast cancer stem cells","volume":"74","author":"Wang","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101981_bib35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massague","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.101981_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","article-title":"Metastatic latency and immune evasion through autocrine inhibition of WNT","volume":"165","author":"Malladi","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.101981_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.coi.2018.08.002","article-title":"When designing vaccines, consider the starting material: the human B cell repertoire","volume":"53","author":"Havenar-Daughton","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.xcrm.2025.101981_bib38","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1172\/JCI80009","article-title":"Therapeutic cancer vaccines","volume":"125","author":"Melief","year":"2015","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.101981_bib39","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.aar7112","article-title":"Personalized vaccines for cancer immunotherapy","volume":"359","author":"Sahin","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.101981_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13045-021-01081-7","article-title":"HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8(+) T and NK cells: a novel therapeutic tumour vaccine","volume":"14","author":"Yu","year":"2021","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2025.101981_bib41","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B cell responses: cell interaction dynamics and decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.101981_bib42","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/bjc.2017.79","article-title":"MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue","volume":"116","author":"Ghadially","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.101981_bib43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ibd.20026","article-title":"Expression of nonclassical class I molecules by intestinal epithelial cells","volume":"13","author":"Perera","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.xcrm.2025.101981_bib44","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1073\/pnas.032668099","article-title":"Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA","volume":"99","author":"Tieng","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.101981_bib45","doi-asserted-by":"crossref","first-page":"L222","DOI":"10.1152\/ajplung.00327.2005","article-title":"NKG2D ligands are expressed on stressed human airway epithelial cells","volume":"291","author":"Borchers","year":"2006","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.xcrm.2025.101981_bib46","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.vaccine.2018.02.115","article-title":"Vaccination of sheep with Quil-A\u00ae adjuvant expands the antibody repertoire to the Fasciola MF6p\/FhHDM-1 antigen and administered together impair the growth and antigen release of flukes","volume":"36","author":"Orbegozo-Medina","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2025.101981_bib47","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.vaccine.2009.01.091","article-title":"Advances in saponin-based adjuvants","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2025.101981_bib48","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T\u00a0cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.101981_bib49","article-title":"Assembly of immunogenic protein particles toward advanced synthetic vaccines","volume":"19","author":"Chen","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.xcrm.2025.101981_bib50","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12885-017-3098-7","article-title":"Enhanced and long term immunogenicity of a Her-2\/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide","volume":"17","author":"Tobias","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2025.101981_bib51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41591-020-01145-0","article-title":"Modeling human adaptive immune responses with tonsil organoids","volume":"27","author":"Wagar","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.101981_bib52","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.immuni.2023.06.019","article-title":"Influenza vaccine format mediates distinct cellular and antibody responses in human immune organoids","volume":"56","author":"Kastenschmidt","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.101981_bib53","first-page":"380","article-title":"A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2","volume":"22","author":"Yin","year":"2023","journal-title":"Nat. Mater."},{"key":"10.1016\/j.xcrm.2025.101981_bib54","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41573-022-00493-5","article-title":"Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities","volume":"21","author":"Kim","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.101981_bib55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2023.11.002","article-title":"Modeling human immune responses to vaccination in\u00a0vitro","volume":"45","author":"Morrocchi","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.xcrm.2025.101981_bib56","first-page":"4106","article-title":"ANKRD22 is involved in the progression of prostate cancer","volume":"18","author":"Qiu","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.xcrm.2025.101981_bib57","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcmgh.2021.06.020","article-title":"ANKRD22 drives rapid proliferation of Lgr5(+) cells and acts as\u00a0a\u00a0promising therapeutic target in gastric mucosal injury","volume":"12","author":"Liu","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2025.101981_bib58","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41596-018-0016-7","article-title":"Metal-isotope-tagged monoclonal antibodies for high-dimensional mass cytometry","volume":"13","author":"Han","year":"2018","journal-title":"Nat. Protoc."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125000540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125000540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T06:19:42Z","timestamp":1742624382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125000540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2666379125000540"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.101981","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An epitope-directed mRNA vaccine inhibits tumor metastasis through the blockade of MICA\/B \u03b11\/2 shedding","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.101981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101981"}}